Peptides, precisely made.
cGMP-Audited Synthesis
HPLC / MS Characterised
SDS and CoA Per Lot
Shipped Across Europe
cGMP-Audited SynthesisHPLC / MS CharacterisedSDS and CoA Per LotShipped Across Europe
Japanese-origin actives. Finished, tested and released in the EU.
The Science
01Provenance
Born in Japan. Finished in Europe.
Every active begins in Japan, where half a century of methodical practice has shaped how peptides are made and verified — then crosses to the European Union to be reconstituted, filled, tested and released under EU good manufacturing practice. Two countries, one uncompromising standard of care, on every vial we ship.
02Characterisation
Identity, purity, lot integrity
Every lot is characterised by reverse-phase HPLC for purity and mass spectrometry for identity, with residual water and counter-ion analysis recorded against specification. A Certificate of Analysis is published per lot, traceable to the batch you receive. We state the figure; we do not round it up.
03Documentation
Transparent and auditable
Every substance is released against a published specification. Safety Data Sheets are compiled per REACH Annex II and retained in accordance with REACH Article 36. Nothing in the catalogue is supplied without a release document.
04Supply
Supplied for research use only
Available to individuals aged 18 and over across the served European countries. The buyer accepts that the products are supplied for research use only and takes sole responsibility for their purchase and use, and for compliance with the laws of their country.
05Classification
Not a medicine
These substances are reference standards supplied for research use only. They are not medicinal products, are not approved or evaluated by the European Medicines Agency or any national regulator, and are not for human or veterinary consumption.
Catalogue
